TUDOR INVESTMENT CORP ET AL - TRANSMEDICS GROUP INC ownership

TRANSMEDICS GROUP INC's ticker is TMDX and the CUSIP is 89377M109. A total of 135 filers reported holding TRANSMEDICS GROUP INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.

Quarter-by-quarter ownership
TUDOR INVESTMENT CORP ET AL ownership history of TRANSMEDICS GROUP INC
ValueSharesWeighting
Q3 2023$2,125,997
+69083.1%
38,831
-4.3%
0.02%
-56.2%
Q1 2023$3,073
-34.7%
40,582
-46.7%
0.05%
-48.4%
Q4 2022$4,704
-99.9%
76,210
-8.2%
0.09%
+24.0%
Q3 2022$3,465,000
+1207.5%
83,006
+885.6%
0.08%
+971.4%
Q2 2022$265,0008,4220.01%
Other shareholders
TRANSMEDICS GROUP INC shareholders Q2 2022
NameSharesValueWeighting ↓
Must Asset Management Inc. 94,202$5,168,86312.65%
Eagle Health Investments LP 414,205$22,677,7245.00%
Ophir Asset Management Pty Ltd 295,761$16,192,9153.82%
Sandhill Capital Partners LLC 732,610$40,110,4093.75%
First Light Asset Management, LLC 618,100$33,840,9753.21%
NEXT CENTURY GROWTH INVESTORS LLC 477,482$26,142,1392.84%
Bullseye Asset Management LLC 70,512$3,8612.15%
Kent Lake Capital LLC 100,000$5,475,0002.10%
Nicholas Investment Partners, LP 413,714$22,650,8421.69%
AtonRa Partners 12,287$672,7131.41%
View complete list of TRANSMEDICS GROUP INC shareholders